Neurocrine Biosciences grants Chief Medical Officer Eiry Roberts 8,314 stock options, 1,506 restricted stock units

PUBT · 19h ago
Neurocrine Biosciences grants Chief Medical Officer Eiry Roberts 8,314 stock options, 1,506 restricted stock units
  • Neurocrine Biosciences granted Chief Medical Officer Eiry Roberts 8,314 stock options on November 4, 2026.
  • Roberts also received 1,506 restricted stock units on the same date.
  • The stock options expire on November 4, 2036.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001727606-26-000007), on November 05, 2026, and is solely responsible for the information contained therein.